CMPX

Compass Therapeutics, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-05

Figures on this page computed 2026-11-08 12:40 UTC

Last close

0.76USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2025, filed 2026-03-05

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001171843-26-001337
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-05
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001171843-26-001337
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-06
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-06
The filing itself
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001171843-26-001337
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001171843-26-001337
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
0.05Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001171843-26-001337
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-06
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Growth is the furthest below its sector's middle: 0.29 against 0.46 on the market's range.

Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.00x

1.39x

1.38x

1.23x

0.26x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-06

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-05

Sales0.00x
Its own average over 3 years, 283.3K.
Profit1.39x
Its own average over 8 years, -47.8M.
Free cash flow1.38x
Its own average over 8 years, -35.6M.
Debt1.23x
Its own average over 8 years, 8.0M.
Price0.26x
Its own average over 6 years, 3. Market data, 2026-11-06

Sales is furthest from its own average, at 0.00 times.

Sales is 0.00 times its own 3-year average; Profit is 1.39 times its own 8-year average; Free cash flow is 1.38 times its own 8-year average; Debt is 1.23 times its own 8-year average; Price is 0.26 times its own 6-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-05

Sales against its own 3-year average0.00
Source
filed
Statement
income
Fiscal year
2025
Accession
0001171843-26-001337
Reported in
USD
The filing itself
Profit against its own 8-year average1.39
Source
filed
Statement
income
Fiscal year
2025
Accession
0001171843-26-001337
Reported in
USD
The filing itself
Free cash flow against its own 8-year average1.38
Source
filed
Statement
income
Fiscal year
2025
Accession
0001171843-26-001337
Reported in
USD
The filing itself
Debt against its own 8-year average1.23
Source
filed
Statement
income
Fiscal year
2025
Accession
0001171843-26-001337
Reported in
USD
The filing itself
Price against its own 6-year average0.26Market data, 2026-11-06
Source
market
Taken on
2026-11-06
Reported in
USD